Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Novel Single Wave Assessment to Measure Cardiac Dysfunction and Metabolic Syndrome in Cancer Patients

NCT04014231 is registered in ClinicalTrials.gov with City of Hope Medical Center as lead sponsor.

NCT NCT04014231
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04014231 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Novel Single Wave Assessment to Measure Cardiac Dysfunction and Metabolic Syndrome in Cancer Patients
Lead sponsor
City of Hope Medical Center
Phase
Observational
Overall status
Completed
Start date
July 21, 2017
Completion date
April 20, 2026
Enrollment
159 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malignant neoplasm